Compass Therapeutics, Inc. · NASDAQ:CMPX
Vivo Opportunity Fund Holdings, L.P. reported a 5.10% stake in Compass Therapeutics, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
Vivo Opportunity Fund Holdings, L.P. reported a 5.10% stake in Compass Therapeutics, Inc., 8,995,979 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 8,995,979
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 5.10% | 8,995,979 |
| Vivo Opportunity, LLC | 5.10% | 8,995,979 |
| Vivo Opportunity Cayman Fund, L.P. | 0.30% | 549,487 |
| Vivo Opportunity Cayman, LLC | 0.30% | 549,487 |
Source
Related
- Compass Therapeutics, Inc.
- Vivo Opportunity, LLC
- Compass Therapeutics, Inc. shareholders
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Form 4 · Lerner Neil · Oct 2, 2026
- Form 4 · Lerner Neil · Sep 25, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Bvf Partners L P · May 15, 2026
- Form 4/A · Lerner Neil · Apr 30, 2026